These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 34052751)
1. Synaptic proteins associated with cognitive performance and neuropathology in older humans revealed by multiplexed fractionated proteomics. Carlyle BC; Kandigian SE; Kreuzer J; Das S; Trombetta BA; Kuo Y; Bennett DA; Schneider JA; Petyuk VA; Kitchen RR; Morris R; Nairn AC; Hyman BT; Haas W; Arnold SE Neurobiol Aging; 2021 Sep; 105():99-114. PubMed ID: 34052751 [TBL] [Abstract][Full Text] [Related]
2. Impact of Alzheimer's pathology on cognitive trajectories in nondemented elderly. Driscoll I; Resnick SM; Troncoso JC; An Y; O'Brien R; Zonderman AB Ann Neurol; 2006 Dec; 60(6):688-95. PubMed ID: 17192929 [TBL] [Abstract][Full Text] [Related]
3. Oxidative stress and hippocampal synaptic protein levels in elderly cognitively intact individuals with Alzheimer's disease pathology. Scheff SW; Ansari MA; Mufson EJ Neurobiol Aging; 2016 Jun; 42():1-12. PubMed ID: 27143416 [TBL] [Abstract][Full Text] [Related]
4. Interrogation of the human cortical peptidome uncovers cell-type specific signatures of cognitive resilience against Alzheimer's disease. Morgan GR; Carlyle BC Sci Rep; 2024 Mar; 14(1):7161. PubMed ID: 38531951 [TBL] [Abstract][Full Text] [Related]
5. Functional Integrity of Synapses in the Central Nervous System of Cognitively Intact Individuals with High Alzheimer's Disease Neuropathology Is Associated with Absence of Synaptic Tau Oligomers. Singh A; Allen D; Fracassi A; Tumurbaatar B; Natarajan C; Scaduto P; Woltjer R; Kayed R; Limon A; Krishnan B; Taglialatela G J Alzheimers Dis; 2020; 78(4):1661-1678. PubMed ID: 33185603 [TBL] [Abstract][Full Text] [Related]
6. Neurodegeneration, synaptic dysfunction, and gliosis are phenotypic of Alzheimer dementia. Merluzzi AP; Carlsson CM; Johnson SC; Schindler SE; Asthana S; Blennow K; Zetterberg H; Bendlin BB Neurology; 2018 Jul; 91(5):e436-e443. PubMed ID: 29959263 [TBL] [Abstract][Full Text] [Related]
7. Relation of neuropathology to cognition in persons without cognitive impairment. Bennett DA; Wilson RS; Boyle PA; Buchman AS; Schneider JA Ann Neurol; 2012 Oct; 72(4):599-609. PubMed ID: 23109154 [TBL] [Abstract][Full Text] [Related]
8. Perforant path synaptic loss correlates with cognitive impairment and Alzheimer's disease in the oldest-old. Robinson JL; Molina-Porcel L; Corrada MM; Raible K; Lee EB; Lee VM; Kawas CH; Trojanowski JQ Brain; 2014 Sep; 137(Pt 9):2578-87. PubMed ID: 25012223 [TBL] [Abstract][Full Text] [Related]
9. Cognitive Resilience to Alzheimer's Disease Pathology in the Human Brain. Aiello Bowles EJ; Crane PK; Walker RL; Chubak J; LaCroix AZ; Anderson ML; Rosenberg D; Keene CD; Larson EB J Alzheimers Dis; 2019; 68(3):1071-1083. PubMed ID: 30909217 [TBL] [Abstract][Full Text] [Related]
10. Alzheimer disease pathology and longitudinal cognitive performance in the oldest-old with no dementia. Balasubramanian AB; Kawas CH; Peltz CB; Brookmeyer R; Corrada MM Neurology; 2012 Aug; 79(9):915-21. PubMed ID: 22895581 [TBL] [Abstract][Full Text] [Related]
11. Resilience of precuneus neurotrophic signaling pathways despite amyloid pathology in prodromal Alzheimer's disease. Perez SE; He B; Nadeem M; Wuu J; Scheff SW; Abrahamson EE; Ikonomovic MD; Mufson EJ Biol Psychiatry; 2015 Apr; 77(8):693-703. PubMed ID: 24529280 [TBL] [Abstract][Full Text] [Related]
13. Selected microRNAs Increase Synaptic Resilience to the Damaging Binding of the Alzheimer's Disease Amyloid Beta Oligomers. Zolochevska O; Taglialatela G Mol Neurobiol; 2020 May; 57(5):2232-2243. PubMed ID: 31997075 [TBL] [Abstract][Full Text] [Related]
14. Genetic variants and functional pathways associated with resilience to Alzheimer's disease. Dumitrescu L; Mahoney ER; Mukherjee S; Lee ML; Bush WS; Engelman CD; Lu Q; Fardo DW; Trittschuh EH; Mez J; Kaczorowski C; Hernandez Saucedo H; Widaman KF; Buckley R; Properzi M; Mormino E; Yang HS; Harrison T; Hedden T; Nho K; Andrews SJ; Tommet D; Hadad N; Sanders RE; Ruderfer DM; Gifford KA; Moore AM; Cambronero F; Zhong X; Raghavan NS; Vardarajan B; ; ; Pericak-Vance MA; Farrer LA; Wang LS; Cruchaga C; Schellenberg G; Cox NJ; Haines JL; Keene CD; Saykin AJ; Larson EB; Sperling RA; Mayeux R; Bennett DA; Schneider JA; Crane PK; Jefferson AL; Hohman TJ Brain; 2020 Aug; 143(8):2561-2575. PubMed ID: 32844198 [TBL] [Abstract][Full Text] [Related]
15. Postsynaptic Protein Shank3a Deficiency Synergizes with Alzheimer's Disease Neuropathology to Impair Cognitive Performance in the 3xTg-AD Murine Model. Landry O; François A; Oye Mintsa Mi-Mba MF; Traversy MT; Tremblay C; Emond V; Bennett DA; Gylys KH; Buxbaum JD; Calon F J Neurosci; 2023 Jun; 43(26):4941-4954. PubMed ID: 37253603 [TBL] [Abstract][Full Text] [Related]
16. Association of Neuropathological Markers in the Parietal Cortex With Antemortem Cognitive Function in Persons With Mild Cognitive Impairment and Alzheimer Disease. Tremblay C; François A; Delay C; Freland L; Vandal M; Bennett DA; Calon F J Neuropathol Exp Neurol; 2017 Feb; 76(2):70-88. PubMed ID: 28158844 [TBL] [Abstract][Full Text] [Related]
17. Integrated Proteomics to Understand the Role of Neuritin (NRN1) as a Mediator of Cognitive Resilience to Alzheimer's Disease. Hurst C; Pugh DA; Abreha MH; Duong DM; Dammer EB; Bennett DA; Herskowitz JH; Seyfried NT Mol Cell Proteomics; 2023 May; 22(5):100542. PubMed ID: 37024090 [TBL] [Abstract][Full Text] [Related]